Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008;336:610-2.↵ Graham J, Baker M, Macbeth F, Titshall V. Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ 2008 ; 336 : 610 -2....
Diagnosis and treatment of prostate cancer: summary of NICE guidance. BMJ. 2008;336:610–2. CentralGraham J, Baker M, Macbeth F, Titshall V, Guideline Development G (2008) Diagnosis and treatment of prostate cancer: summary of NICE guidance. Bmj 336(7644):610–612. : 10.1136/...
Draft scoping document for NICE guidance on interventions to reduce the rates of premature death in disadvantaged areas and consultation feedback form. Sickness and Incapacity 被引量: 119发表: 2007年 Prostate Cancer: Diagnosis and Treatment (Supplement) As part of the Prostate Cancer guideline develo...
Epigenetic changes in prostate cancer: implication for diagnosis and treatment. Prostate cancer is the most common noncutaneous malignancy and the second leading cause of cancer death among men in the United States. DNA methylation and... LC Li,PR Carroll,R Dahiya - 《Journal of the National C...
1.1. Epidemiology of Prostate Cancer Worldwide, cancer is one of the main causes of death and mortality leading to a decrease or stagnation in life expectancy (Han and Choi, 2021; Sung et al., 2021). PCa is the second most common cancer diagnosis in men and the fifth leading cause of ...
There is a continuing lack of evidence that screening for prostate cancer results in a significant improvement in survival and/or quality of life of men with the disease. Moreover, there is a growing concern that the introduction of a national prostate c
Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer — 2020 update. Part 1: screening, diagnosis, and local treatment with curative intent.Eur. Urol.79, 243–262 (2021). ArticleGoogle Scholar Mason, B. R. et al. Current status of MRI and PET in the NCCN guidel...
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for men presenting with suspected prostate cancer, with a negative MRI enabling safe avoidance of biopsy and a positive result enabling MRI-directed sampling of lesions. The diagnostic pathway consists of several step...
FOX: Joe and Ali, you're also the parents of a young child. How did being somewhat new parents affect the whole prostate cancer diagnosis and treatment? Joe: Part of my recovery is being able to hang out with my 3-year-old. Because it really takes your mind off of [the cancer]. ...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th